The Enterprise Value as of December 2025 (TTM) for Grace Therapeutics, Inc. (GRCE) is 29.50M

According to Grace Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 29.50M. This represents a change of 19.18% compared to the average of 24.75M of the last 4 quarters.

Grace Therapeutics, Inc. (GRCE) Historical Enterprise Value (quarterly & annually)

How has GRCE Enterprise Value performed in the past?

The mean historical Enterprise Value of Grace Therapeutics, Inc. over the last ten years is -8019332.05. The current 29.50M Enterprise Value has changed -36883.48% with respect to the historical average. Over the past ten years (40 quarters), GRCE's Enterprise Value was at its highest in in the December 2024 quarter at 31.98M. The Enterprise Value was at its lowest in in the March 2020 quarter at -45361245.00.

Grace Therapeutics, Inc. (GRCE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Grace Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Grace Therapeutics, Inc. (GRCE) Average Enterprise Value

How has GRCE Enterprise Value performed in the past?

The current Enterprise Value of Grace Therapeutics, Inc. (GRCE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Grace Therapeutics, Inc. (GRCE) Enterprise Value vs. Peers

How is GRCE’s Enterprise Value compared to its peers?

Grace Therapeutics, Inc.’s Enterprise Value is greater than LAVA Therapeutics N.V. (19.39M), greater than Tvardi Therapeutics, Inc. (18.02M), greater than Actinium Pharmaceuticals, Inc. (-7013958.00), greater than PDS Biotechnology Corporation (-26077209422.00), less than CalciMedica, Inc. (60.38M), greater than Xilio Therapeutics, Inc. (-57598257.00), less than Lantern Pharma Inc. (36.25M), greater than OnKure Therapeutics, Inc. (-34012234.00), greater than RenovoRx, Inc. (22.76M), less than ABVC BioPharma, Inc. (37.86M),

Build a custom stock screener for Grace Therapeutics, Inc. (GRCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grace Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Grace Therapeutics, Inc. (GRCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Grace Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.